Literature DB >> 6167633

Characterization of an anti-H-2 monoclonal antibody and its use in large-scale antigen purification.

K C Stallcup, T A Springer, M F Mescher.   

Abstract

A rat anti-mouse monoclonal antibody (MAb), M1/42, has been found to react with H-2 antigens from cells of the a, b, d, j, k, s, and u haplotypes (all haplotypes tested). This antibody, when bound to cells and reacted with FITC-conjugated anti-rat Ig, could be used to quantitate H-2 expression on several cell types. The antibody was also useful in comparing the H-2 products precipitated from a variety of haplotypes. M1/42-coupled Sepharose-4B beads were used to purify H-2d antigens by affinity chromatography. Pure H-2 molecules eluted from the column in 0.5% DOC, 0.65 M NaCl, 20 mM Tris, pH 8.0, yielding 110 to 180 micrograms H-2d/10(10) P815 tumor cells. This antibody, when used in series with H-2Kk-specific MAb 11-4.1, allowed purification of Dk and Dd from RDM-4 and YAC cells, respectively. H-2d purified by column chromatography on M1/42 was found to be serologically and biologically active, as determined by MAb rebinding, inhibition of cell lysis by alloantisera plus complement and ability to stimulate alloreactive CTL. This antibody and the described protocols should be useful in the preparation of relatively large quantities of a number of H-2 antigens.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6167633

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Induction of autoreactive CD8+ cytotoxic T cells during Theiler's murine encephalomyelitis virus infection: implications for autoimmunity.

Authors:  Ikuo Tsunoda; Li-Qing Kuang; Robert S Fujinami
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Identification of cell surface receptors for the 86-kilodalton glycoprotein of human cytomegalovirus.

Authors:  S Keay; T C Merigan; L Rasmussen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  Cytotoxic T-lymphocyte interaction with fibronectin and vitronectin: activated adhesion and cosignalling.

Authors:  B Ybarrondo; A M O'Rourke; J B McCarthy; M F Mescher
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

4.  Reassociation with beta 2-microglobulin is necessary for Kb class I major histocompatibility complex binding of exogenous peptides.

Authors:  K L Rock; L E Rothstein; S R Gamble; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  Mechanism of escape of endogenous murine leukemia virus emv-14 from recognition by anti-AKR/Gross virus cytolytic T lymphocytes.

Authors:  H D White; M D Robbins; W R Green
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  Low temperature and peptides favor the formation of class I heterodimers on RMA-S cells at the cell surface.

Authors:  K L Rock; C Gramm; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

7.  Perceiving the avidity of T cell activation can be translated into peripheral T cell regulation.

Authors:  Weiling Chen; Linging Zhang; Bitao Liang; Yvonne Saenger; Jianfeng Li; Leonard Chess; Hong Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

8.  Costimulatory signal provided by a B-lymphoblastoid cell line and its Ia-negative variant.

Authors:  H Reiser; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Overexpressed Ly-6A.2 mediates cell-cell adhesion by binding a ligand expressed on lymphoid cells.

Authors:  A Bamezai; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity.

Authors:  Y Watanabe; K Kuribayashi; S Miyatake; K Nishihara; E Nakayama; T Taniyama; T Sakata
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.